Michele Spinetta is the Corporate Market Research Lead at MENARINI Group, where he has spent over 20 years driving market insights and strategy. Before joining MENARINI, he worked in Market Research and as a Business Analyst at Novo Nordisk A/S, and held roles outside the pharmaceutical industry at companies such as ABN Amro and Microsoft.

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 609 million packets of product a year and distribute them to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world.